Advertisement
News
Subscribe to MDT Magazine News

Medtronic gets OK for scan-friendly pacemaker

February 8, 2011 10:45 am | by The Associated Press | Comments

Medtronic Inc., the world's largest medical device company, said Tuesday it has received U.S. approval for the first pacemaker designed to be safely used with MRI scanners.Patients with the heart-pacing implants are strongly discouraged from having MRI scans because the radio waves could...

Moody's puts Beckman Coulter debt on review

February 8, 2011 10:45 am | by The Associated Press | Comments

Moody's Investors Service said Tuesday it put the debt of medical equipment maker Beckman Coulter Inc. on review for a possible upgrade after news that the company will be purchased by rival equipment maker Danaher Corp.The ratings agency also put a "Baa3" rating on Beckman Coulter's $1.4...

Beckman Coulter to pay final dividend

February 8, 2011 10:45 am | by The Associated Press | Comments

Medical testing instrument maker Beckman Coulter Inc. said Tuesday it will pay a quarterly dividend of 19 cents per share.The dividend is payable on March 13 to stockholders of record on March 3.The company expects it to be the final dividend payout pending completion of the merger with Danaher...

Advertisement

Centene 4Q profit rises 7 percent

February 8, 2011 9:45 am | by The Associated Press | Comments

Medicaid coverage provider Centene Corp. said Tuesday its fourth-quarter earnings rose 7 percent on membership growth and higher premium rates.The company earned $25.4 million, or 50 cents per share, up from $23.7 million, or 53 cents per share, during the same period a year prior. Centene had...

Speedy generic approval may not benefit consumers as much as expected, Rotman model shows

February 8, 2011 9:39 am | by EurekAlert | Comments

(University of Toronto, Rotman School of Management) Faster approval times for generic drugs will get them into consumers' hands quicker, but may not make the price any better, a pricing and marketing researcher has found.A mathematical model created by Andrew Ching shows that...

TOPICS:

Aushon in research deal with Peking University Cancer Hospital

February 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Microarray and immunoassay company Aushon BioSystems Inc. of Billerica said it has signed a diagnostic development collaboration letter of intent with Peking University Cancer Hospital (PUCH) in Beijing.

Pervasis hemodialysis treatment lands FDA fast-track review

February 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has granted fast track review status to Cambridge biotech Pervasis Therapeutics Inc. for Vascugel, its lead drug program, a prevention treatment of kidney dialysis access failure in patients with end stage renal disease.

Rib-X moves skin infection treatment to Phase 2b trial

February 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Rib-X Pharmaceuticals Inc., an antibiotics company in New Haven, Conn., has begun a Phase 2b clinical trial of its treatments for acute bacterial skin and skin structure infections (ABSSSI).

Advertisement

Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience

February 8, 2011 9:37 am | by Bio-Medicine.Org | Comments

DALLAS, Feb. 8, 2011 /- Targetbase , a leading U.S.-based direct marketing agency known for its expertise in understanding consumer data, translating that data into intelligence, and using it to produce effective creative with measurable results, today announced that Peter Dannenfelser...

TOPICS:

New FDLI's Food and Drug Policy Forum Focuses on Liability Issues in Vaccine Design Defect Claims

February 8, 2011 9:37 am | by Bio-Medicine.Org | Comments

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States,...

TOPICS:

February 10 Town Hall Meeting to Explain DC's New Medical Marijuana Program

February 8, 2011 9:37 am | by Bio-Medicine.Org | Comments

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The District of Columbia Patients Cooperative (DCPC), a taxable non-profit corporation that formed one year ago to provide high quality and affordable medical "marijuana" to qualifying DC patients will host a "Town Hall" meeting about...

TOPICS:

Optasia gets FDA clearance on spinal imaging analyzer

February 8, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | Comments

Radiological imaging software company Optasia Medical of Sudbury has received 510(k) clearance from the U.S. Food and Drug Administration to market its SpineAnalyzer systems in the U.S.

TOPICS:

Late nights can lead to higher risk of strokes and heart attacks(2)

February 8, 2011 8:41 am | by EurekAlert | Comments

(University of Warwick) New research from Warwick Medical School published today in the European Heart Journal shows that prolonged sleep deprivation and disrupted sleep patterns can be linked to strokes, heart attacks and cardiovascular disorders which often result in early death.

TOPICS:

Late nights can lead to higher risk of strokes and heart attacks

February 8, 2011 8:40 am | Comments

University of Warwick

New silicon photonics foundry

February 8, 2011 7:37 am | by I-Micronews | Comments

Intel-backed OpSIS officially kicked off on February 1, and is now looking for partners and to recruit staff interested in silicon photonics.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading